The COVID-19 Vaccine and the Future of International Laws in Business, Travel, and Trade
DOI:
https://doi.org/10.18034/ajtp.v8i2.564Keywords:
COVID, Doha declaration, intellectual property, travel, international business, trade, international lawAbstract
Since COVID-19, the world has been constantly evolving to adapt. Finding a cure quickly became the focus worldwide which altered set approaches to intellectual property rights. Additionally, creating a controversial vaccine has led to several more questions for the future. With varying vaccines and standards throughout the world, travel, business, and trade may face new challenges which change the current systems.
Downloads
Download data is not yet available.
Downloads
Published
2021-08-09
Issue
Section
Law Reviews
License
American Journal of Trade and Policy is an Open Access journal. Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a CC BY-NC 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of their work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. We require authors to inform us of any instances of re-publication.
How to Cite
Lane, M. (2021). The COVID-19 Vaccine and the Future of International Laws in Business, Travel, and Trade. American Journal of Trade and Policy, 8(2), 183-198. https://doi.org/10.18034/ajtp.v8i2.564
